Phloroglucinol-mediated Hsp70 production in crustaceans : protection against Vibrio parahaemolyticus in Artemia franciscana and Macrobrachium rosenbergii by Kumar, Vikash et al.
May 2018 | Volume 9 | Article 10911
Original research
published: 22 May 2018
doi: 10.3389/fimmu.2018.01091
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Chu-Fang Lo, 
Center for Shrimp Disease Control 
and Genetic Improvement, 
Taiwan
Reviewed by: 
Anchalee Tassanakajon, 
Chulalongkorn University, Thailand 
Iddya Karunasagar, 
Nitte University, India  
Annalisa Pinsino, 
Istituto di biomedicina e di 
immunologia molecolare Alberto 
Monroy (IBIM), Italy
*Correspondence:
Kartik Baruah 
kartik.baruah@slu.se
†Present address: 
Kartik Baruah, 
Department of Animal Nutrition and 
Management, Faculty of Veterinary 
Medicine and Animal Sciences, 
Swedish University of Agricultural 
Sciences, Uppsala, Sweden
Specialty section: 
This article was submitted to 
Comparative Immunology, 
a section of the journal 
Frontiers in Immunology
Received: 06 February 2018
Accepted: 01 May 2018
Published: 22 May 2018
Citation: 
Kumar V, Baruah K, Nguyen DV, 
Smagghe G, Vossen E and Bossier P 
(2018) Phloroglucinol-Mediated 
Hsp70 Production in Crustaceans: 
Protection against Vibrio 
parahaemolyticus in Artemia 
franciscana and Macrobrachium 
rosenbergii. 
Front. Immunol. 9:1091. 
doi: 10.3389/fimmu.2018.01091
Phloroglucinol-Mediated hsp70 
Production in crustaceans: 
Protection against Vibrio 
parahaemolyticus in Artemia 
franciscana and Macrobrachium 
rosenbergii
Vikash Kumar1,2, Kartik Baruah1*†, Dung Viet Nguyen1, Guy Smagghe3, Els Vossen4  
and Peter Bossier1
1 Laboratory of Aquaculture & Artemia Reference Center, Department of Animal Sciences and Aquatic Ecology, Faculty of 
Bioscience Engineering, Ghent University, Ghent, Belgium, 2 ICAR-Central Inland Fisheries Research Institute (CIFRI), 
Barrackpore, India, 3 Department of Crop Protection, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium, 
4 Laboratory of Animal Nutrition and Animal Product Quality, Department of Animal Sciences and Aquatic Ecology, Faculty of 
Bioscience Engineering, Ghent University, Ghent, Belgium
The halophilic aquatic bacterium, Vibrio parahaemolyticus, is an important aquatic 
pathogen, also capable of causing acute hepatopancreatic necrosis disease (AHPND) 
in shrimp resulting in significant economic losses. Therefore, there is an urgent need 
to develop anti-infective strategies to control AHPND. The gnotobiotic Artemia model 
is used to establish whether a phenolic compound phloroglucinol is effective against 
the AHPND strain V. parahaemolyticus MO904. We found that pretreatment with phlo-
roglucinol, at an optimum concentration (30 µM), protects axenic brine shrimp larvae 
against V. parahaemolyticus infection and induced heat shock protein 70 (Hsp70) 
production (twofolds or more) as compared with the control. We further demonstrated 
that the Vibrio-protective effect of phloroglucinol was caused by its prooxidant effect 
and is linked to the induction of Hsp70. In addition, RNA interference confirms that 
phloroglucinol-induced Hsp70 mediates the survival of brine shrimp larvae against 
V. parahaemolyticus infection. The study was validated in xenic Artemia model and in a 
Macrobrachium rosenbergii system. Pretreatment of xenic brine shrimp larvae (30 µM) 
and Macrobrachium larvae (5 µM) with phloroglucinol increases the survival of xenic brine 
shrimp and Macrobrachium larvae against subsequent V. parahaemolyticus challenge. 
Taken together, our study provides substantial evidence that the prooxidant activity 
of phloroglucinol induces Hsp70 production protecting brine shrimp, A. franciscana, 
and freshwater shrimp, M. rosenbergii, against the AHPND V. parahaemolyticus strain 
MO904. Probably, phloroglucinol treatment might become part of a holistic strategy to 
control AHPND in shrimp.
Keywords: gnotobiotic Artemia, Vibrio parahaemolyticus, phloroglucinol, heat shock protein 70, Macrobrachium 
rosenbergii
Table 1 | AP3 primers used for confirmation of V. parahaemolyticus AHPND strains.
aP3 5'–3' length % gc Tm Ta expected amplicon
Forward ATGAGTAACAATATAAAACATGAAAC 26 23.08 57.63 53 336 bp
Reverse GTGGTAATAGATTGTACAGAA 21 33.33 55.46
2
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inTrODUcTiOn
The acute hepatopancreatic necrosis disease (AHPND), originally 
known as early mortality syndrome, is a newly emerging shrimp 
disease causing havoc in the shrimp industry (1). The disease 
is caused by a specific virulent strain of Gram-negative marine 
bacterium, Vibrio parahaemolyticus, ubiquitous in estuarine and 
coastal waters (2). Since the AHPND outbreak first appeared in 
China in 2009, it has spread to Vietnam (2010), Malaysia (2011), 
Thailand (2012), Mexico (2013), Philippines (2015), and South 
America (2016) (3, 4). The shrimp production in AHPND-affected 
regions has dropped to ~60%, and the disease has caused global 
loss of $1 billion per year to the shrimp farming industry (5, 6). 
The V. parahaemolyticus becomes virulent VPAHPND by acquiring 
a 63- to 70-kb plasmid (pVA1) encoding the binary toxin PirAVp/
PirBVp, which consist of two subunits PirA and PirB, and is 
homologous to the Photorhabdus luminescens insect-related (Pir) 
toxins PirA/PirB (7–9). Therefore, to enable the prevention of 
V. parahaemolyticus, an approach that focuses on understanding 
the host immune system and develops effective anti-infective 
strategies, in general, will have the highest chance of decreasing 
the risk of pathogenic V. parahaemolyticus infection in shrimps.
The conventional approach so far applied in the mitigation or 
cure of V. parahaemolyticus such as antibiotics and disinfectants 
had limited success (10). In addition, their usage in the food-
producing sector is under severe scientific and public scrutiny 
due to the development of multiple resistances (11). Because 
of such concerns, there is an urgent need for the development 
of polyphenol plant-derived compounds or natural products 
that protect the shrimp and enhance the immune reactivity to 
V. parahaemolyticus. However, the critical problem in studying the 
anti-pathogenic effects of a polyphenol plant-based compound 
in vivo is the difficulty to either eliminate or extricate the effect 
of the microbial communities that occur naturally in the system 
(12). In addition, in germ-associated conditions, the compound 
of interest is either metabolized by microbial communities or 
influences the physiology of host-associated microbes, thereby 
making it difficult to understand the host response toward tested 
compound (13). Consequently, the selection of appropriate 
animal model system that permits better delineation of the 
biological effects of polyphenol plant-based compounds is para-
mount, for instance, on the induction of resistance to disease.
The brine shrimp (Artemia franciscana), an aquatic inverte-
brate that can be reared under gnotobiotic conditions (allowing 
full control over the host-associated microbial communities), is 
characteristically small, highly osmotolerant, branchiopod crus-
tacean reported from a variety of harsh environment worldwide 
(14). Apart from its unusual life history, relatively low space and 
cost requirement for culture, rapid generation cycle (cyst to adult 
in 20–30  days), well-characterized developmental stages, the 
ability to form cyst that can be stored and used, and established 
molecular techniques like RNA interference (RNAi) make 
A. franciscana an exceptional experimental system to study the 
biological activity of polyphenol plant-based compounds as it 
allows to distinguish the direct effect on the host (by pre-exposing 
axenic brine shrimp larvae to the compound for a certain 
duration) from indirect effects (15–18).
Given the potential of polyphenol plant-based compound, 
phloroglucinol, as an anti-infective agent, understanding the 
underlying mechanism of action of this compound is considered 
vital. In this study, using a highly controlled gnotobiotic 
brine shrimp model system, we aimed to investigate whether 
phloroglucinol potentiates the generation of prooxidant 
activity and heat shock protein 70 (Hsp70) production in vivo 
and whether this putative effect could contribute to the induc-
tion of protective responses in Artemia against pathogenic 
V. parahaemolyticus MO904 strain. Furthermore, we also 
unraveled the mechanism behind the possible Hsp70-inducing 
effect of phloroglucinol. The results obtained in the gnotobiotic 
brine shrimp model system were validated in a xenic brine 
shrimp and Macrobrachium larvae, and we present novel find-
ing which demonstrates that phloroglucinol is indeed a potent 
in vivo enhancer of Hsp70 and this effect mediates the induc-
tion of resistance in xenic brine shrimp and Macrobrachium 
larvae against V. parahaemolyticus.
MaTerials anD MeThODs
bacterial strains for In Vivo challenge 
Tests
In total, seven bacterial strains were used in the study: 
V. parahaemolyticus (AHPND strains) KM, MO605, RY, MO903, 
MO904, non-AHPND strain CAIM170, and Aeromonas 
hydrophila LVS3. LVS3 (autoclaved) were used as feed for brine 
shrimp larvae and MO904 as a pathogen for the challenge assay. 
The V. parahaemolyticus strains were confirmed for AHPND 
bacteria by PCR using AP3 primers (Table  1). Based on the 
amplification of DNA sequence of V. parahaemolyticus strains, 
it was confirmed as AHPND-causing strain that is not present in 
non-AHPND V. parahaemolyticus (Figure S1 in Supplementary 
Material) (19, 20). Before the challenge assay, the virulence of 
V. parahaemolyticus AHPND strains (KM, MO605, RY, MO903, 
and MO904) and non-AHPND strain (CAIM170) was evaluated 
using axenic Artemia as host. The V. parahaemolyticus MO904 
strain provoking significant mortality in brine shrimp larvae up 
to 80% after 48  h was selected for the experimental challenge 
(Figure S2 in Supplementary Material). The MO904 strain 
used in the experiment was collected from the collection of 
aquatic important microorganism, CIAD, A.C. Mazatlàn unit 
of Aquaculture, Mazatlàn, Sinaloa, Mexico, and the isolates have 
been transferred to the Laboratory of Aquaculture and Artemia 
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Reference Center, Ghent University, Belgium, under material 
transfer agreement in 2013. The stock culture of MO904 was 
streaked onto Luria Bertani agar plates (Himedia, India) contain-
ing 2% NaCl (LB+) to obtain pure colonies. A single colony was 
inoculated into LB+ broth (Himedia, USA), incubated overnight 
at 28°C under constant agitation (100/min), and the stocked 
culture was prepared in 40% glycerol and stored in −80°C. The 
LVS3 stock culture collected from the Laboratory of Aquaculture 
and Artemia Reference Center, Ghent University, Belgium, was 
streaked onto Marine agar plates (Difco Laboratories, Detroit, 
MI, USA). For cultivation, a single colony was inoculated in 
Marine broth (Difco Laboratories, Detroit, MI, USA).
reagents
Phloroglucinol (≥99%) purchased from Sigma-Aldrich (Diegem, 
Belgium) was dissolved in sterile distilled water at 0.4  g/l 
(3.17 mM). Superoxide dismutase (SOD) (2,000–6,000 units/mg 
protein) and catalase (2,000–5,000 units/mg protein) were also 
obtained from Sigma-Aldrich. Catalase was dissolved in sterile 
distilled water at 0.5 g/l as stock solution. All the stock solutions 
were prepared fresh for each experiment.
gnotobiotic brine shrimp rearing system
The gnotobiotic brine shrimp larvae were produced by 
hatching brine shrimp cysts axenically (germ-free) following 
decapsulation and hatching procedures as described by Baruah 
et al. (21). Briefly, 1.5 g of cysts (EG® type, batch 21452, INVE 
Aquaculture, Dendermonde, Belgium) were hydrated in 89 ml 
of distilled water for 1 h. Sterile cysts and larvae were obtained 
via decapsulation using 3.3 ml NaOH (32%) and 50 ml NaOCl 
(50%). During the reaction, 0.2-µm filtered aeration was 
provided. All manipulation was carried out under a laminar 
flow hood and all tools were sterilized. The decapsulation was 
stopped after 2  min by adding 50  ml Na2S2O3 at 10  g/l. The 
decapsulated cysts were washed with filtered autoclaved sea-
water (FASW) containing 35  g/l of instant ocean® synthetic 
sea salt (Aquarium Systems, Sarrebourg, France). The cysts, 
suspended in 1-l glass bottles containing FASW, were incubated 
at 28°C for 28 h for hatching with a constant illumination of 
approximately 27 μE/m2 s. The hatched larvae at developmental 
stage instar II (mouth is opened to ingest particles) were col-
lected, and the axenicity was verified by spread plating (100 ml) 
as well as by adding (500-µl) hatching water on Marine Agar 
and Marine Broth, respectively, followed by incubation at 28°C 
for 5  days (22). Experiments that started with non-axenic 
larvae were discarded.
brine shrimp lethality Test and challenge 
assay
In total, four separate challenge tests were performed. The first 
test determined the dose–response relationship (protective effect) 
of phloroglucinol. Briefly, hatched brine shrimp larvae (at devel-
opmental stage II) were collected and counted volumetrically. 
Firstly, the sub-samples (1 ml) were tallied, and this number was 
multiplied by the total measured volume (ml) of hatched larvae. 
Thereafter, the larvae were transferred to sterile 50-ml falcon 
tubes containing 30 ml. The axenic larvae were pretreated with 
increasing concentrations of phloroglucinol (5, 10, 20, 30, 40, 50, 
and 100 µM) for 2 h at 28°C. They were repeatedly rinsed with 
FASW to wash away the compound and then allowed to recover 
for 2 h at 28°C. Following recovery period, a group of 20 larvae 
were transferred to sterile 40-ml glass tubes containing 10-ml 
FASW. Afterward, it was verified whether the pretreatment of 
phloroglucinol can protect the larvae against subsequent chal-
lenge with V. parahaemolyticus MO904 strain at 107 cells/ml. 
The survival of Artemia was scored 48 h after the addition of the 
pathogen. The non-pretreated larvae that were either challenged 
with V. parahaemolyticus or not were maintained as negative 
and positive controls. Each treatment and control were done in 
quintuplicate.
In the second test, the cytotoxic effect of phloroglucinol was 
determined in the axenic brine shrimp larvae as previously 
described by Baruah et al. (13). The axenic larvae were pretreated 
with an increasing concentration of phloroglucinol as described 
above in the dose–response study. Subsequently following recov-
ery period, toxicity assay was performed in sterile 40-ml glass 
tubes with 20 larvae in 10-ml FASW per tube. The toxicity of the 
compound was determined after 48 h by scoring the number of 
survivors as previously described (13). Brine shrimp larvae that 
did not receive the phloroglucinol pretreatment served as control 
group. Five replicates were maintained for each treatment and 
control groups.
The third and fourth tests were performed to determine 
the mode of action of phloroglucinol. The axenic brine shrimp 
larvae were pretreated with an optimized dose of phloroglucinol 
(a dose that gave maximum protection to challenged larvae in 
the dose–response assay), a mixture of the antioxidant enzymes 
catalase (10  mg/l) and SOD (75 units), or a combination of 
phloroglucinol and antioxidant enzymes mixture in a similar 
manner as described above. The larvae in the control group 
did not undergo any pretreatment. Groups of 20 larvae were 
counted and distributed in sterile 40-ml glass tubes and then 
challenged with V. parahaemolyticus MO904 strain as described 
in the dose–response study. The survival of larvae was scored 
2 days after the addition of pathogen. Brine shrimp larvae that 
did not receive phloroglucinol pretreatment either challenged 
with V. parahaemolyticus or not served as negative and positive 
controls. Each treatment and control were performed in five 
replicates.
Protein extraction and Detection of hsp70 
in brine shrimp larvae
Following pretreatment with phloroglucinol, antioxidant 
enzymes, and a mixture of antioxidant enzymes and phloro-
glucinol, live brine shrimp larvae (0.1  g w/v) were collected, 
rinsed in distilled water, immediately frozen in liquid nitrogen, 
and stored in −80°C. Artemia samples were homogenized in 
cold buffer K (150  mM sorbitol, 70  mM potassium gluconate, 
5  mM MgCl2, 5  mM NaH2PO4, 40  mM HEPES, pH 7.4) (23), 
supplemented with protease inhibitor cocktail (Sigma-Aldrich®, 
USA). Subsequently, the samples were centrifuged at 2,200 × g 
for 1 min at 4°C, and the supernatant protein concentration was 
4Kumar et al. Crustacean Hsp70 Production against AHPND
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1091
determined by the Bradford method (24) using bovine serum 
albumin as standard. Supernatant samples were then combined 
with loading buffer, vortexed, heated for 5  min at 95°C, and 
electrophoresed in 10% SDS-PAGE gel (BioRad, Belgium), with 
each lane receiving an equivalent amount of protein. HeLa (heat-
shocked) cells (Enzo Life Sciences, USA) (6 µg) were loaded on 
to one well to serve as a positive control. Gels were then either 
stained with Coomassie Biosafe (BioRad Laboratories) or trans-
ferred to polyvinylidene fluoride membrane (BioRad Immuno-
Blot™ PVDF) for antibody probing. Membrane was incubated 
with a blocking buffer [50  ml of 1× phosphate-buffered saline 
containing 0.2% (v/v) tween 20 and 5% (w/v) bovine serum 
albumin] for 60 min at room temperature and then with mouse 
monoclonal anti-Hsp70 antibody (3  A3) (Affinity BioReagents 
Incl., Golden, CO, USA), at the recommended dilution of 1:5,000 
(22). Horseradish peroxidase-conjugated donkey anti-mouse IgG 
was used as secondary antibody at the recommended dilution 
of 1:2,500 (Affinity BioReagents Incl., Golden, CO, USA). The 
membrane was then incubated with clarity western ECL substrate 
(chemiluminescence reagent) (BioRad Laboratories) for 5 min, 
and the signals were detected by a ChemiDoc MP imaging system 
(BioRad, Belgium).
lipid Peroxidation
The extent of lipid peroxidation was measured by the methods 
of Grotto et al. (25), and malondialdehyde (MDA) was deter-
mined calorimetrically. In brief, gnotobiotic brine shrimp 
larvae were pretreated with an optimized dose (30  µM) of 
phloroglucinol for 2  h at 28°C. They were repeatedly rinsed 
with FASW to wash away the compound and then allowed to 
recover for 2  h at 28°C. Following the recovery period, the 
samples containing 0.1  g (w/v) of live larvae were harvested 
from treatment and control and immediately frozen in liquid 
nitrogen and stored at −80°C for further MDA determination. 
The samples were hydrolyzed in mild alkaline conditions 
(1.5 M NaOH) at 60°C for 30 min in order to release bound 
MDA. The mixture was incubated with 6% H3PO4 and 0.8% 
thiobarbituric acid at 90°C for 45 min. After cooling, 10% SDS 
was added and the chromophore was extracted with n-butanol 
and absorbance was measured at 532  nm. The results were 
expressed as nmol MDA/g of Artemia.
culture of A. franciscana for 
Microinjection
Approximately, 1.5  g of brine shrimp cysts was hydrated in 
89  ml of distilled water for 1  h. Sterile cysts and larvae were 
collected following decapsulation as described above. The cysts, 
suspended in 1-l glass bottles containing FASW, were incubated 
at 28°C for 28  h for hatching with a constant illumination of 
approximately 27  μE/m2 s. Hatched larvae at developmental 
stage instar II (stage at which mouth is open to ingest particles) 
were collected and transferred to 2-l glass bottles containing 
FASW. The larvae were fed daily with non-axenic green algae 
(Tetraselmis suecica) and grown to adults in a controlled tem-
perature room (28°C) with a constant illumination of approxi-
mately 27 μE/m2 s (26).
Preparation of dsrna of A. franciscana 
hsp70 and green Fluorescence Protein 
(gfp)
The dsRNA specific to the A. franciscana hsp70 (GenBank: 
AF427596.1) gene transcript was amplified (436 bp) using gene-
specific primers (forward primer: 5' GATGCAGGTGCCATTGC 3' 
and reverse primer: 5' AGCTCCTCAAAACGGGC 3'); each primer 
included the T7 promoter (5' TAATACGACTCACTATAGGG 3') 
at their 5' ends. The PCR was performed at 94°C for 3  min, 
followed by 35 cycles of 94°C for 25 s, 53°C for 25 s, and 72°C 
for 2 min, and then the final extension at 72°C for 5 min. The 
purified PCR product was used as a template to generate dsRNA 
by using the MEGAscript RNAi kit (Ambion, USA), and the 
in  vitro transcription reaction was performed according to the 
manufacturer’s instructions. Briefly, PCR-purified product was 
incubated overnight at 37°C with four ribonucleotides (ATP, 
CTP, GTP, and UTP), T7 enzyme mix, and reaction buffer. 
Then, the dsRNA was incubated at 37°C for 1  h with DNase I 
and RNAse for nuclease digestion to remove any template DNA 
and ssRNA that did not anneal. The hsp70 dsRNA, quantified 
in Nanodrop spectrophotometer (ThermoFisher Scientific, 
Belgium), was subjected to 1.5% agarose gel electrophoresis in 
order to check the integrity and efficiency of duplex formation. 
In addition, a gfp fragment (455bp) was amplified to prepare 
dsRNA of gfp, which served as a negative control using primers 
(forward 5' AGAGCGCTTCTCGTTGGGG 3' and reverse 5' 
AGACCTGAAGTTCATCTGC 3'); each primer included the T7 
promoter (5' TAATACGACTCACTATAGGG 3') at their 5' ends.
Microinjection of Artemia Females With 
dsrna
The dsRNA specific to hsp70 and gfp was mixed separately in 
1:10 ratio (v/v) with 0.5% phenol red in Dulbecco’s phosphate-
buffered saline (Sigma-Aldrich). The diluted dsRNA either hsp70 
or gfp (250 nl of solution containing approximately 80 ng dsRNA) 
was injected with a FemtoJet® microinjector (Eppendorf, USA) 
using Femtotips II microinjection capillary tips (Eppendorf, 
USA) to egg sacs of adult Artemia female while viewing under 
stereomicroscope (Figure S3 in Supplementary Material) (18). 
A total of thirty numbers of females were injected with dsRNA 
for each hsp70 and gfp. Injected females were observed for 2 h, 
and the animals that retained dye, remained healthy, and could 
swim properly were employed for further experiments (Figure 
S4 in Supplementary Material). Mating pairs, i.e., injected adult 
female and male, were transferred to individual well in a 6-well 
plate containing 35  ppt artificial sea water. The Artemia pairs 
were fed daily with green algae, T. suecica, and maintained in a 
controlled temperature room (28°C) with a constant illumination 
of approximately 27 μE/m2 s. After 5 days, larvae were collected 
from each mating pairs (injected with dsRNA hsp70 and gfp) for 
further analysis.
brine shrimp challenge assay
The brine shrimp larvae obtained from a single female injected 
with dsRNA specific to either hsp70 or gfp were collected, 
counted, and thereafter transferred to sterile 50-ml falcon tubes 
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containing 30-ml FASW. The larvae were pretreated with an 
optimized dose of phloroglucinol for 2  h at 28°C. They were 
rinsed repeatedly with FASW to wash away the compound and 
then allowed to recover for 2 h at 28°C. Following recovery, the 
larvae were transferred to sterile 40-ml glass tubes containing 
10  ml of FASW. Subsequently, the tubes were inoculated with 
V. parahaemolyticus MO904 strain at 107 cells/ml. The survival 
of Artemia was scored 48  h after the addition of a pathogen. 
The brine shrimp larvae, obtained from either hsp70 or gfp 
dsRNA-injected females, which did not receive phloroglucinol 
pretreatment, and either challenged with V. parahaemolyticus or 
not, served as negative and positive controls.
Detection of hsp70 mrna and hsp70 
Protein in brine shrimp larvae
The larvae released from Artemia females injected with either hsp70 
or gfp dsRNA were transferred to sterile 50-ml falcon tubes con-
taining 30-ml FASW. The larvae were pretreated with an optimized 
dose of phloroglucinol for 2 h at 28°C. They were rinsed repeatedly 
with FASW to wash away the compound and then allowed to 
recover for 2 h at 28°C. Subsequently, the larvae were washed with 
sterile distilled water, counted (20 nos.), and collected in 1.5-ml 
sterile eppendorf tubes. The larvae were homogenized with a ster-
ile microfuge pestle in 100 µl of TRIzol® reagent (Invitrogen, USA) 
(15, 18). The homogenate was centrifuged at 12,000 × g for 10 min at 
4°C, and the supernatant was transferred to new sterile eppendorf 
tubes prior to RNA isolation according to the manufacturer’s pro-
tocols. An equal amount of larvae RNA (determined by NanoDrop 
spectrophotometer, ThermoFisher Scientific, Belgium) was used 
for cDNA synthesis, using Superscript® III First-Strand synthesis 
supermix for qRT-PCR kit (Invitrogen, USA). Subsequently, 5 µl of 
cDNA product was used for PCR amplification of hsp70 using the 
forward and reverse primers (as described above). PCR products 
were resolved in 1.5% (w/v) agarose gel, stained with GelRed™ 
nucleic acid gel stain, and visualized by ChemiDoc MP imaging 
system (BioRad, Belgium).
For the detection of Hsp70 protein in larvae from females 
injected with dsRNA specific to either hsp70 or gfp, the larvae 
were pretreated with an optimized dose of phloroglucinol as 
described above. Following pretreatment, 20 larvae (washed in 
sterile DW) were collected in 1.5-ml sterile eppendorf tubes. The 
larvae were homogenized in an equal volume of loading buffer 
(5 µl), vortexed, heated for 5 min at 95°C, and 15 µl of each sam-
ple was resolved in 10% SDS-PAGE gel (BioRad, Belgium) (15). 
Subsequently, Hsp70 protein is detected as described previously 
in Section “Protein Extraction and Detection of Hsp70 in Brine 
Shrimp Larvae.”
Xenic brine shrimp challenge assay
Brine shrimp cysts were hatched in xenic (germ-associated) 
condition, following decapsulation and hatching procedures as 
described by Sorgeloos et al. (27) and Baruah et al. (21), and brine 
shrimp larvae were collected after 28 h, at developmental stage II. 
The dose–response relationship of phloroglucinol was performed 
as described previously by Ref. (22) with slight modification. 
Briefly, the hatched brine shrimp larvae were collected, counted 
volumetrically, and thereafter transferred to 50-ml falcon tubes 
containing 30-ml seawater. The larvae were pretreated with 
increasing doses of phloroglucinol (1, 2.5, 5, 10, 20, 30, 40, 50, 
and 100 µM) for 2 h at 28°C. The larvae were rinsed repeatedly 
with seawater to wash away the compound and then allowed to 
recover for 2 h. Following recovery period, a group of 20 larvae 
were transferred to 40-ml glass tubes containing 10 ml of seawater. 
Subsequently, the tubes were inoculated with V. parahaemolyticus 
MO904 strain at 107 cells/ml, and the Artemia therein was fed 
with autoclaved LVS3 (107 cells/ml). The survival of Artemia was 
scored 2 days after the addition of pathogen, and each treatment 
was done in quintuplicate.
Macrobrachium rosenbergii rearing 
system
The experiments were carried out at the Laboratory of Aqua-
culture & Artemia Reference Center, Ghent University, Belgium, 
in a controlled temperature room. Acclimatized adult freshwater 
shrimp (M. rosenbergii) obtained from laboratory and main-
tained in four separate freshwater recirculation units were used 
as brooders. For each experiment, larvae from single ovigerous 
female breeder were used. Matured female with fully ripe ferti-
lized eggs (indicated by dark gray eggs) were transferred to the 
hatching tanks (30  l) containing brackish water (6 g/l salinity). 
Twenty-four hours after hatching, the larvae were collected and 
stocked in two separate brackish water (12 g/l salinity) recircula-
tion units and fed with newly hatched axenic brine shrimp larvae. 
The broodstock management techniques were followed as previ-
ously described (28, 29).
Macrobrachium lethality Test and 
challenge assay
In total, four separate experiments were performed in a controlled 
temperature room. In the first experiment, it was determined 
whether V. parahaemolyticus MO904 strain could cause infection 
in Macrobrachium larvae, and to this end, a dose–response study 
was determined. A group of 10 Macrobrachium larvae (8 days old) 
were collected and transferred to 150-ml glass tubes containing 
100-ml sterile brackish water (12 g/l salinity) (29). Subsequently, 
the larvae were exposed to four doses (104, 105, 106, and 107 
cells/ml of total rearing water) of V. parahaemolyticus MO904 
strain. Macrobrachium larvae that were not challenged with 
V. parahaemolyticus served as negative control. Survival was 
scored at 12, 24, 36, and 48 h after the addition of the pathogen. 
The V. parahaemolyticus dose-inducing mortality of prawn larvae 
near to 80% in 24 h was considered as an optimum infectious dose 
and selected for the experimental challenge.
In the second experiment, the cytotoxic effect of phloroglucinol 
was determined in M. rosenbergii larvae as previously described 
by Baruah et al. (13). The larvae were pretreated with an increas-
ing concentration of phloroglucinol as described above in the 
M. rosenbergii dose–response study. Subsequently following 
recover period, toxicity assay was performed in sterile 150-ml 
glass tubes with 10 larvae in 100-ml sterile brackish water (12 g/l 
salinity) per tube. The toxicity of compound was determined 
after 12, 24, 36, and 48 h by scoring the number of survivors as 
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previously described (13). The larvae that did not receive the 
phloroglucinol pretreatment served as negative control. Each 
treatment and control were performed in three replicates.
In third and fourth experiments, the protective effect of 
phloroglucinol was determined. In brief, Macrobrachium larvae 
(8 days old) were collected, counted, and transferred to 500-ml 
sterile glass bottle containing sterile brackish water (12  g/l 
salinity). The larvae were pretreated with increasing concentra-
tions of phloroglucinol (1, 2.5, 5, 10, 20, and 30 µM) for 2 h at 
28°C. They were rinsed repeatedly with brackish water to wash 
away the compound and then allowed to recover for 2  h at 
28°C. Following the recovery period, a group of 10 larvae were 
transferred to sterile 150-ml glass tubes containing 100-ml sterile 
brackish water (12  g/l salinity). Subsequently, the tubes were 
inoculated with V. parahaemolyticus MO904 strain at 106 cells/ml. 
The survival of larvae was scored 12, 24, 36, and 48 h after the 
addition of pathogen. Macrobrachium larvae that did not receive 
phloroglucinol pretreatment either challenged or not challenged 
with V. parahaemolyticus served as negative and positive controls.
Detection of hsp70 in Macrobrachium 
larvae
Following pretreatment with phloroglucinol, live Macrobrachium 
larvae (0.1 g w/v) were rinsed in sterile distilled water, collected in 
1.5-ml sterile eppendorf tubes, and immediately frozen in liquid 
nitrogen and stored in −80°C. The samples were homogenized 
and processed for protein extraction as described above. The 
protein concentration was determined by the Bradford method 
(24) using bovine serum albumin as standard. The supernatant 
samples of Macrobrachium larvae were then electrophoresed in 
10% SDS-PAGE gel (BioRad, Belgium) and transferred to poly-
vinylidene fluoride membrane (BioRad Immuno-Blot™ PVDF) 
for antibody probing to detect Hsp70 protein as described previ-
ously in the above section.
statistical analysis
Survival data were arcsin transformed to satisfy normality and 
homoscedasticity requirements as necessary. The data were then 
subjected to one-way analysis of variances (ANOVA) followed by 
Duncan’s multiple range test using statistical software statistical 
package for the social sciences version 24.0. The effect of RNAi on 
survival of brine shrimp larvae was analyzed by two-way ANOVA. 
P-values of ≤0.001 were considered significant. Survival data of 
M. rosenbergii were subjected to logistic regression analysis using 
GenStat 16 (VSN International, Hemel Hempstead, UK) to deter-
mine significant differences between the control and the treatment.
resUlTs
Phloroglucinol Pretreatment of axenic 
brine shrimp larvae Protects Them 
against subsequent V. parahaemolyticus 
challenge and is associated With hsp70 
induction
In the first experiment, we investigated whether phloroglu-
cinol could confer protection to the host Artemia against 
V. parahaemolyticus MO904 strain, which can cause AHPND in 
shrimp (Figure S5 in Supplementary Material). We found that 
brine shrimp larvae that received phloroglucinol pretreatment 
in the range of 5–100 µM exhibited a significant increase in the 
survival compared to positive control. However, the maximum 
survival (11-folds or more) was observed at a concentration of 
30 µM (Figure 1A). By contrast, the survival of brine shrimp 
larvae pretreated with phloroglucinol higher than 30  µM 
appeared to decrease. Therefore, we next investigated whether it 
was due to a toxic effect of phloroglucinol. Brine shrimp larvae 
exposed with phloroglucinol in the range of 5–100 µM did not 
exhibit any significant difference in survival when compared 
with unexposed, control larvae (Figure 1B). This result indi-
cates that phloroglucinol appeared to be nontoxic to the experi-
mental animal under the present experimental conditions. 
Next, to determine whether the induction of Hsp70 may be a 
mechanism supporting the resistance of phloroglucinol-treated 
brine shrimp larvae against V. parahaemolyticus challenge, we 
analyzed the temporal induction profile of Hsp70 in vivo, since 
the role of inducible Hsp70 in eliciting protective immunity 
against bacterial infection has been previously described 
(12, 13, 17, 20, 30, 31). Interestingly, we found that phloroglu-
cinol pretreatment significantly increased Hsp70 production 
(twofolds or more) in brine shrimp larvae as compared with the 
control (Figure  1C). This result suggests that phloroglucinol 
is an effective inducer of Hsp70 and the protective effect of 
phloroglucinol is paralleled with the Hsp70 induction.
Phloroglucinol-generated Prooxidant 
activity Mediates the Protective response 
in brine shrimp larvae
We next sought to investigate the mechanism of action of 
phloroglucinol in inducing Hsp70 within Artemia. Since reac-
tive oxygen species (e.g., hydrogen peroxide, H2O2) generated 
from the polyphenolic compounds has been linked with Hsp70 
induction (17, 32), we hypothesized that phloroglucinol induced 
Hsp70 by the mechanism of generating ROS and that eliminat-
ing these molecules by using ROS-scavenging enzymes, the 
phloroglucinol-mediated Hsp70 induction can be neutralized. 
We verified these findings by two alternative approaches. We 
found that brine shrimp larvae pretreated with phloroglucinol 
showed a significant increase in the survival and Hsp70 pro-
duction (Figures  2A,B). However, co-pretreatment of larvae 
with phloroglucinol and antioxidant enzyme mixture resulted 
in a significant decrease in the survival and Hsp70 produc-
tion as compared to the larvae pretreated with phloroglucinol 
(Figures 2A,B). We also further examined the prooxidant char-
acteristics (i.e., generation of ROS: hydrogen peroxide, H2O2) 
of the phloroglucinol through lipid peroxidation by analyzing 
MDA content in the phloroglucinol-treated brine shrimp larvae. 
We found that pretreated larvae have significantly higher MDA 
content/g Artemia when compared with the negative control 
larvae (Figure  2C). These results indicate that prooxidant 
activity generated by phloroglucinol in the Artemia appeared to 
be, at least in part, involved in the induction of Hsp70 within 
brine shrimp larvae.
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Knockdown of hsp70 by rnai reduces 
the Tolerance of brine shrimp larvae to  
V. parahaemolyticus infection
There exists a correlation between the amount of induced 
Hsp70 and the degree of improved protective response against 
V. parahaemolyticus. To gain insight into the molecular bases for 
the observed effects, we used RNAi to assess the role of Hsp70 
in protecting brine shrimp larvae against V. parahaemolyticus 
MO904 strain. As RNAi-mediated gene-silencing technique has 
been very frequently used to investigate the function of critical 
genes involved in the immune response (18, 33–36), we have 
prepared dsRNA specific to Hsp70 and injected A. franciscana 
females in order to eliminate Hsp70 mRNA and protein from 
larvae released from these females. At first, we have examined 
the effect of Hsp70 knockdown on the survival of larvae released 
from females injected with either hsp70 dsRNA or gfp. We found 
that larvae lacking or containing Hsp70 survived equally after 
being released from injected females and Hsp70 knockdown did 
not affect the viability of brine shrimp larvae. Furthermore, our 
analysis revealed that phloroglucinol pretreatment to larvae col-
lected from females injected with either hsp70 dsRNA (−Hsp70) 
or gfp (+Hsp70) showed a significant difference in the survival 
against V. parahaemolyticus (Figure 3A). The survival was sig-
nificantly increased (~6-folds) in the pretreated larvae containing 
Hsp70 when compared with larvae lacking Hsp70 (Table S1). We 
therefore reasoned that the difference in the survival of larvae 
might be due to the difference in the expression of Hsp70. To test 
the hypothesis that dsRNA may have knockdown hsp70 mRNA 
and protein, we have analyzed hsp70 mRNA and Hsp70 protein 
in A. franciscana larvae collected from females injected with 
dsRNA. We found that females injected with hsp70 dsRNA 
knockdown the hsp70 mRNA in larvae (Figure 3B). Furthermore, 
the Western blot analysis of Hsp70 protein showed that Hsp70 
was absent in the larvae released by females injected with dsRNA 
hsp70, but not in the larvae from females injected with gfp dsRNA 
(Figure 3C). These results therefore confirm that phloroglucinol-
mediated Hsp70 production plays an essential role in providing 
protection against V. parahaemolyticus MO904 strain.
C
a
b
FigUre 1 | Phloroglucinol pretreatment of axenic brine shrimp larvae protects them against subsequent Vibrio parahaemolyticus challenge and is associated with 
heat shock protein (Hsp70) induction. (a) Survival (%) of phloroglucinol-pretreated brine shrimp larvae after 48 h of challenge with V. parahaemolyticus MO904. The 
larvae were pretreated with phloroglucinol at the indicated doses for 2 h, rinsed to wash away the compound, and then allowed to recover for 2 h. The larvae were 
subsequently challenged with V. parahaemolyticus at 107 cells/ml of rearing water. Non-pretreated larvae that were either challenged with V. parahaemolyticus 
(positive control) or unchallenged (negative control) served as controls. Error bars represent the standard error of five replicates; different letters indicate significant 
differences (P < 0.001). (b) Toxicity of phloroglucinol to gnotobiotic brine shrimp larvae. The larvae were pretreated with phloroglucinol at the indicated doses for 2 h, 
rinsed to wash away the compound, and then allowed to recover for 2 h. Non-pretreated larvae served as negative controls. Survival was recorded 48 h after the 
recovery period. Error bars represent the standard error of five replicates; different letters indicate significant differences (P < 0.001). (c) Induction of Hsp70 protein 
in brine shrimp larvae pretreated with phloroglucinol (30 µM). Non-pretreated larvae were maintained as control. (a) Protein extracted from control and treatment 
groups was resolved on an SDS-PAGE gel and then transferred to a polyvinylidene fluoride membrane and probed with an antibody to brine shrimp Hsp70. 
Molecular mass standards (M) in kilodaltons (protein ladder) are shown on the left. The induction of Hsp70 in HeLa cells was regarded as 1. (b) Quantitative analysis 
of Hsp70 levels in brine shrimp larvae is presented relative to Hsp70 production in HeLa cells. Error bars represent the standard error of three replicates; different 
letters indicate significant differences (P < 0.001).
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Pretreatment of Xenic brine shrimp 
larvae and Macrobrachium larvae With 
Phloroglucinol Protects Them against 
subsequent V. parahaemolyticus 
challenge
To further confirm the contribution of phloroglucinol on 
the survival of xenic brine shrimp and Macrobrachium 
larvae against V. parahaemolyticus, we conducted additional 
in vivo survival assay as described in Figure 4. We assumed 
that phloroglucinol imparts protection to xenic brine 
shrimp larvae against V. parahaemolyticus infection and 
does not have any significant difference when compared 
with gnotobiotic brine shrimp larvae. Second, we have used 
M. rosenbergii system to further verify that phloroglucinol 
mediates the production of Hsp70 and induces resistance in 
Macrobrachium larvae against pathogenic V. parahaemolyticus  
MO904 strain.
bC
FigUre 2 | Phloroglucinol-generated prooxidant activity mediates the protective response in brine shrimp larvae. (a) Survival (%) of brine shrimp larvae pretreated 
with antioxidant enzymes, phloroglucinol, or in combination with both (antioxidant enzymes and phloroglucinol) after 48 h of challenge with Vibrio parahaemolyticus 
MO904. The larvae were pretreated with antioxidant enzymes (catalase, 10 mg/l and superoxide dismutase (SOD), 75 units), phloroglucinol (30 µM), and mixture of 
antioxidant enzymes and phloroglucinol for 2 h, rinsed to wash away the compound, and then allowed to recover for 2 h. The larvae were subsequently challenged 
with V. parahaemolyticus at 107 cells/ml of rearing water. Non-pretreated larvae that were either challenged with V. parahaemolyticus (positive control) and those not 
challenged with V. parahaemolyticus (negative control) served as controls. Error bars represent the standard error of five replicates; different letters indicate 
significant differences (P < 0.001). (b) Induction of heat shock protein (Hsp70) protein in brine shrimp larvae. The brine shrimp larvae were pretreated with 
antioxidant enzymes, phloroglucinol, or in combination with both (antioxidant enzymes and phloroglucinol) as described in Figure 2a. Non-pretreated larvae were 
maintained as control. (a) Protein extracted from different treatment groups was resolved on an SDS-PAGE gel and then transferred to a polyvinylidene fluoride 
membrane and probed with an antibody to brine shrimp Hsp70. Molecular mass standards (M) in kilodaltons are shown on the left. The induction of Hsp70 in HeLa 
cells was regarded as 1. (b) Quantitative analysis of Hsp70 levels in the brine shrimp larvae is presented relative to Hsp70 production in HeLa cells. Error bars 
represent the standard error of three replicates; different letters indicate significant differences (P < 0.001). (c) Effect of phloroglucinol on lipid peroxidation in brine 
shrimp larvae. Lipid peroxidation is expressed as malondialdehyde (MDA) content in each sample. The larvae were pretreated with phloroglucinol (30 µM) for 2 h, 
rinsed to wash away the compound, and then allowed to recover for 2 h. The larvae were subsequently collected and analyzed for MDA/g of Artemia. Non-
pretreated larvae were maintained as control. Error bars represent the standard error of two independent samples; asterisks represent significant difference between 
the control and the treatment, *P < 0.001.
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In Vivo confirmation in Xenic brine shrimp 
larvae
We investigated whether phloroglucinol contributes to the 
induction of protective response in xenic brine shrimp larvae 
against V. parahaemolyticus MO904 strain. In agreement with the 
gnotobiotic brine shrimp larvae survival results, we found that 
xenic brine shrimp larvae pretreated with varying concentrations 
of phloroglucinol protect larvae when subsequently challenged 
with pathogenic V. parahaemolyticus (Figure  4A). Moreover, 
the survival was recorded maximum (six times or more) at a 
AB
C
FigUre 3 | Knockdown of heat shock protein 70 (Hsp70) by RNA interference (RNAi) reduces the tolerance of brine shrimp larvae to Vibrio parahaemolyticus 
infection. (a) Hsp70 protects brine shrimp larvae against V. parahaemolyticus MO904. Brine shrimp larvae obtained from females injected with either gfp (+Hsp70) 
or hsp70 dsRNA (−Hsp70) were pretreated with phloroglucinol (30 µM) for 2 h, rinsed to wash away the compound, and then allowed to recover for 2 h. The larvae 
were subsequently challenged with V. parahaemolyticus at 107 cells/ml. Phloroglucinol non-pretreated larvae with and without hsp70 that were challenged with  
V. parahaemolyticus served as positive control. Error bars represent the standard error of six replicates; asterisks represent significant difference between the control 
and the treatment, *P < 0.001. (b) Knockdown of hsp70 mRNA in brine shrimp larvae. Equal amounts of RNA from brine shrimp larvae were amplified by RT-PCR 
and the products were resolved by electrophoresis in agarose gels. M—100 bp DNA ladder, Lane 1—wild-type brine shrimp larvae, Lane 2—brine shrimp larvae 
injected with dsRNA gfp, Lane 3—brine shrimp larvae injected with dsRNA hsp70, Lane 4—wild-type brine shrimp larvae pretreated with phloroglucinol, Lane 
5—brine shrimp larvae injected with dsRNA gfp and pretreated with phloroglucinol, Lane 6—brine shrimp larvae injected with dsRNA hsp70 and pretreated with 
phloroglucinol. (c) Knockdown of Hsp70 protein in brine shrimp larvae. The brine shrimp larvae from females injected with dsRNA for either gfp or hsp70 were 
resolved by electrophoresis in SDS polyacrylamide gels, blotted to nitrocellulose, and probed with Hsp70 antibody (3A3). The secondary antibody was HRP-
conjugated donkey anti-mouse IgG. M—Protein ladder in kilodaltons, Lanes 1–3—wild-type brine shrimp larvae, Lanes 4–6—wild-type brine shrimp larvae 
pretreated with phloroglucinol, Lanes 7–9—brine shrimp larvae injected with dsRNA gfp and pretreated with phloroglucinol, Lanes 10–12—brine shrimp larvae 
injected with dsRNA hsp70 and pretreated with phloroglucinol.
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concentration of 30 µM when compared with the control larvae. 
The phloroglucinol pretreatment at a concentration higher 
than 30  µM did not further improve the larvae survival. By 
contrast, survival tended to decrease with further increase in the 
concentration.
Further Validation in M. rosenbergii
In the validation experiment, the efficiency of phloroglucinol to 
protect Macrobrachium larvae from V. parahaemolyticus infection 
was investigated. At first, we have examined the optimum dose of 
V. parahaemolyticus MO904 strain required for the dose–response 
study. We found that M. rosenbergii post larvae (8  days old) 
when exposed to four infectious doses of V. parahaemolyticus  
(104, 105, 106, and 107 cells/ml) showed a significant difference 
in the survival of larvae (Figure  4B). The V. parahaemolyticus 
infectious dose, 106 cells/ml, provoking a significant mortal-
ity near to 80% at 24 h, was considered an optimum dose and 
selected for the experimental challenge.
Earlier in the study, it is shown that phloroglucinol induces 
the Hsp70 production and protects brine shrimp larvae from 
V. parahaemolyticus infection. This has led to the suggestion 
that phloroglucinol might have a protective response in other 
shrimp species, e.g., freshwater shrimp, M. rosenbergii. To test 
the hypothesis, we first investigated whether phloroglucinol pre-
treatment has a significant role in the survival of Macrobrachium 
larvae, and we found that larvae pretreated with phloroglucinol 
showed a significant increase (sevenfolds or more) in the sur-
vival as compared to the control (positive control) (Figure 4C). 
We have also investigated whether the phloroglucinol has some 
toxic effect on the larvae of Macrobrachium, since the survival 
AB
C
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of larvae pretreated above 5 µM phloroglucinol concentration 
appeared to decrease. We found that phloroglucinol pretreat-
ment does not have any toxic effect on the experimental animals 
(Figure 4D). In the next experiment, we examined whether an 
observed increase in the survival of larvae is related to the increase 
in the Hsp70 production. We found that Hsp70 production 
increased significantly (twofolds or more) in the Macrobrachium 
larvae pretreated with phloroglucinol as compared to the control 
(Figure 4E). These results indicate that phloroglucinol stimu-
lates the Hsp70 production in larvae, which may be involved in 
DE
a
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FigUre 4 | Pretreatment of xenic brine shrimp larvae and Macrobrachium larvae with phloroglucinol protects them against subsequent Vibrio parahaemolyticus 
challenge. (a) Survival (%) of phloroglucinol-pretreated xenic brine shrimp larvae after 48 h of challenge with V. parahaemolyticus MO904. The larvae were pretreated 
with phloroglucinol at the indicated doses for 2 h, rinsed to wash away the compound, and then allowed to recover for 2 h. The larvae were subsequently 
challenged with V. parahaemolyticus at 107 cells/ml of rearing water. Non-pretreated larvae that were either challenged with V. parahaemolyticus (positive control) or 
unchallenged (negative control) served as controls. Error bars represent the standard error of five replicates; different letters indicate significant differences 
(P < 0.001). (b) Proportion of survived of Macrobrachium larvae (8 days old) after 12, 24, 36, and 48 h post challenge with V. parahaemolyticus MO904 strain. Four 
infectious doses (104, 105, 106, and 107 cells/ml) were tested in the Macrobrachium larvae. The V. parahaemolyticus dose provoking significant mortality near to 80% 
at 24 h in Macrobrachium larvae was considered an optimum dose and selected for the experimental challenge. The unchallenged was served as negative controls. 
Values are presented as mean ± SE (n = 3). (c) The effect of phloroglucinol pretreatment on the survival of Macrobrachium larvae (8 days old) after 12, 24, 36, and 
48 h post challenge with V. parahaemolyticus. The larvae were pretreated with phloroglucinol at the indicated doses for 2 h, rinsed to wash away the compound, 
and then allowed to recover for 2 h. The Macrobrachium larvae were subsequently challenged with V. parahaemolyticus at 106 cells/ml of rearing water. Non-
pretreated larvae that were either challenged with V. parahaemolyticus (positive control) and those not challenged with V. parahaemolyticus (negative control) served 
as controls. Values are presented as mean ± SE (n = 3). Asterisks represent significant difference between the control and the treatment. *P < 0.05, **P < 0.01, 
***P < 0.001, ****P < 0.0001, *****P < 0.00001, ******P < 0.000001, *******P < 0.0000001. (D) Toxicity of phloroglucinol to Macrobrachium larvae (8 days old). The 
larvae were pretreated with phloroglucinol at the indicated doses for 2 h, rinsed to wash away the compound, and then allowed to recover for 2 h. Non-pretreated 
larvae served as controls. Survival was recorded 48 h after the recovery period. Values are presented as mean ± SE (n = 3). (e) Induction of Hsp70 protein in 
Macrobrachium larvae (8 days old) pretreated with phloroglucinol at indicated doses. Non-pretreated larvae were maintained as control. (a) Protein extracted from 
different treatment groups was resolved on an SDS-PAGE gel and then transferred to a polyvinylidene fluoride membrane and probed with an antibody to brine 
shrimp Hsp70. Molecular mass standards (M) in kilodaltons are shown on the left. The induction of Hsp70 in HeLa cells was regarded as 1. (b) Quantitative analysis 
of Hsp70 levels in the brine shrimp larvae is presented relative to Hsp70 production in HeLa cells. Error bars represent the standard error of three replicates; different 
letters indicate significant differences (P < 0.001).
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eliciting immune response and protects Macrobrachium larvae 
from pathogenic V. parahaemolyticus infection.
DiscUssiOn
The bacterial species, V. parahaemolyticus and especially 
AHPND-causing strains, such as MO904 are a major cause of 
infectious disease and mortality in wild and cultured shrimp 
species (1, 3). The AHPND strains of V. parahaemolyticus after 
acquiring a plasmid (pVA1) (63–70  kb) express deadly toxin 
PirAVP and PirBVP that damages the shrimp tissue, primarily the 
hepatopancrease (Hp) R (resorptive) cells, B (blister) cells, F 
(fibrillar) cells, and E (embryonic cells), resulting in the shrink-
age of Hp tubular epithelial cells and sloughing of Hp tubular 
lumen (36). The larval stages of shrimp species, in general, are 
more susceptible to the pathogenic V. parahaemolyticus, and the 
infection develops quickly, starting approximately after 8  days 
of post-larvae stocking, and severe mortalities occur during the 
first 20–30 days of culture (37). This motivated us to develop an 
infection model for AHPND using gnotobiotic Artemia, and we 
found that V. parahaemolyticus MO904 strain indeed could cause 
mortality in axenic Artemia. Subsequent studies were carried 
out to validate these findings under xenic condition, and results 
showed that MO904 strain was virulent to both xenic Artemia 
and Macrobrachium larvae. However, it remains to be established 
whether the mortality is PirAVP and PirBVP mediated. It would 
especially be of interest to establish which cells would be affected 
by PirAVP and PirBVP.
The ability to stimulate defense system of invertebrate is con-
sidered to be central to control the pathogenesis of many micro-
bial pathogens (17). In case of brine shrimp that lacks acquired 
immune system and depends on innate immune factors to build 
up resistance against microbial pathogens (like other invertebrate 
species), eliciting innate immune response might be a potential 
preventive modality for the control of biotic and abiotic stressors 
in aquaculture production system (33, 34, 38–41). Previous works 
have shown that the ability of natural/plant-based compounds 
to increase the resistance of host against bacterial infection is 
probably facilitating enhanced immune response (12, 20, 27, 38). 
Although the functional significance of natural or plant-based 
compounds in providing protection to Artemia against bacte-
rial infection by a mechanism of inducing Hsp70 is reported in 
these studies, the role of natural/plant-based compounds against 
V. parahaemolyticus and the molecular mechanism behind the 
protective effect in host remain to be established. In this study, 
using gnotobiotic Artemia model system, it was shown that 
phloroglucinol, a polyphenol plant-based compound, isolated 
from marine brown algae belonging to the family Laminariaceae, 
containing 1,3,5-trihydroxy benzene as the basic moiety (42), 
provides protection to brine shrimp larvae against V. parahaemo-
lyticus MO904 strain.
The ability of polyphenol plant-based compounds to induce 
resistance in host and prevent the microbial infection is func-
tionally dependent on antioxidant property, prooxidant activity, 
and antimicrobial effects (12, 43, 44). Our results indicate that 
pretreatment of phloroglucinol exerted a protective effect in brine 
shrimp larvae against V. parahaemolyticus by mechanism of its 
prooxidant activity (e.g., generation of hydrogen peroxide, H2O2) 
(Figures 2A–C). In fact, such protective effect of phloroglucinol 
was not observed if the generation of reactive oxygen species was 
counteracted by the addition of antioxidant enzyme mixture (SOD 
and catalase) (Figure  2A) (17). In addition, we have also pro-
vided evidence for a link between the phloroglucinol prooxidant 
action and an increase in the Hsp70 protein levels, which might 
stimulate the immune response instigating resistance against 
V. parahaemolyticus in the brine shrimp larvae. This assumption 
is supported by the observation that the protective phenomenon 
was not observed when the induction of Hsp70 was inhibited 
by the ROS-scavenging enzymes mixture (Figures  2A,B) and 
consistent with the known beneficial roles that Hsp70 plays in 
defining the tolerance of organism to bacterial infection by elicit-
ing the protective immunity (33, 45, 46).
However, phloroglucinol-mediated Hsp70 induction may 
represent only one of the possible underlying mechanisms. 
Hence, we used RNAi-mediated gene-silencing technique, to 
unravel the molecular mechanism behind the observed protec-
tive effect of the compound in protecting the brine shrimp larvae 
against V. parahaemolyticus (16, 18, 36). Our results indicate 
that increased survival in brine shrimp larvae pretreated with 
phloroglucinol is most likely due to a significant increase 
in Hsp70 production (Figures  3A–C). This is due to the fact 
that such protective effect of phloroglucinol was not observed 
if the adult Artemia females were injected with hsp70 dsRNA. 
Therefore, our result provides here new insight on the mode of 
Hsp70-inducing action of phloroglucinol, in which the initial 
generation of prooxidant activity by the compound plays a key 
role in Hsp70 induction and protection of brine shrimp larvae 
against V. parahaemolyticus infection.
As for the gnotobiotic A. franciscana, we found that phloro-
glucinol has a protective response against V. parahaemolyticus. 
This led to postulate us that phloroglucinol might be contribut-
ing in the protection of xenic brine shrimp larvae and other 
shrimp species (e.g., M. rosenbergii) against V. parahaemolyticus. 
However, it is hard to generalize from the results of gnotobiotic 
A. franciscana alone because, first under germ-associated condi-
tion, the physiological response (increased prooxidant activity 
and Hsp70 production) in the host due to exposure of tested 
compound could simply reflect the influence of various micro-
bial communities (LPS or other cellular component) rather than 
a genuine biological effect of the compound (46, 47). Second, it 
may be possible that the protective effect of phloroglucinol might 
be different in another host–pathogen model (i.e., M. rosenbergii–
V. parahaemolyticus). Therefore, to address this question, we 
have analyzed xenic brine shrimp larvae and Macrobrachium 
larvae response against phloroglucinol and V. parahaemolyticus. 
We found that xenic brine shrimp larvae pretreated with phlo-
roglucinol displayed a significantly increased survival of larvae 
against pathogenic V. parahaemolyticus infection (Figure  4A), 
and in agreement with gnotobiotic A. franciscana results, we 
therefore suggest that phloroglucinol induces resistance in 
brine shrimp larvae in both gnotobiotic and germ-associated 
conditions against V. parahaemolyticus. Furthermore, in case of 
M. rosenbergii, we provided evidence that phloroglucinol exerted 
a protective effect against V. parahaemolyticus by the induction 
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of Hsp70, which might be involved in eliciting immune response 
in the host (Figures 4C,E) (32, 48, 49).
In conclusion, the results presented here provide new insight 
on the mode of action of phloroglucinol, as a novel inducer of 
prooxidant activity and Hsp70. Our finding also provides strong 
evidences that phloroglucinol-mediated Hsp70 production seems 
to be responsible for generating resistance against a pathogenic 
V. parahaemolyticus MO904 strain that can cause AHPND in 
shrimps. The ability of phloroglucinol to boost immunity and 
induce resistance in A. franciscana and M. rosenbergii makes 
phloroglucinol a potent biocontrol agent that may be valuable to 
avert V. parahaemolyticus infection in other shrimp species. The 
results obtained add new information about the mode of action 
of phloroglucinol and advance our knowledge of this compound 
as a potential disease-mitigating agent.
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